Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli
- Autores
- Silva, Clara del Valle; Nader, Maria Elena Fatima
- Año de publicación
- 2006
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- This study was perfomed to evaluate the effect of the treatment of norfloxacin, as an antimicrobial agent, on the uropathogenic Escherichia coli colonization in mice, complemented by Lactobacilli as probiotics. Norfloxacin (5.5 mg. Kg-1 dose) was administred orally before and after the challenge with E. coli. The animals were also inoculated intra-urethrally with agarose beads containing L. fermentum. The population of the microorganisms in the urogenital tract was measured various days throughout the study. Using either 1 or 3 doses of norfloxacion befor or after the animal had been challenged with E. coli bacteria, reduced the E. coli population the urinary tract. The Norfloxacin treatment after the animals were administered 1 or 3 doses of agarose beads of lactobacilli significantly affected the viability of the lactic acid bacteria in all of the urinary tract organs and the number of E. coly (regardless to when the antibiotic was inoculated) was lower in the mice treated with lactobacilli than in the non-lactobacilli treated mice. Eventhough the survival of the lactobacilli was highly affected by the norfloxacin treatment, the uropathogenic E. coli colonization always decreased more than the lactobacilli population did and often completely disappeared in those animals which were treated with both norfloxacin and probiotic lactobacilli. Through this experimental model one can conclude that lactobacilli increases the effectiveness of the norfloxacin medication in the prevention and treatment of UTI produced by E. coli. Further studies are being performed to determine the mechanisms involved in this probiotic effect.
Fil: Silva, Clara del Valle. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina
Fil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina - Materia
-
Probiotics
Norfloxacin
Urinary Tract Infections
Prevention
E. Coli
L. Fermentum
Recurrence - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/58961
Ver los metadatos del registro completo
id |
CONICETDig_7db276b0203fbc9c81ecb0e264e71170 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/58961 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic LactobacilliSilva, Clara del ValleNader, Maria Elena FatimaProbioticsNorfloxacinUrinary Tract InfectionsPreventionE. ColiL. FermentumRecurrencehttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1This study was perfomed to evaluate the effect of the treatment of norfloxacin, as an antimicrobial agent, on the uropathogenic Escherichia coli colonization in mice, complemented by Lactobacilli as probiotics. Norfloxacin (5.5 mg. Kg-1 dose) was administred orally before and after the challenge with E. coli. The animals were also inoculated intra-urethrally with agarose beads containing L. fermentum. The population of the microorganisms in the urogenital tract was measured various days throughout the study. Using either 1 or 3 doses of norfloxacion befor or after the animal had been challenged with E. coli bacteria, reduced the E. coli population the urinary tract. The Norfloxacin treatment after the animals were administered 1 or 3 doses of agarose beads of lactobacilli significantly affected the viability of the lactic acid bacteria in all of the urinary tract organs and the number of E. coly (regardless to when the antibiotic was inoculated) was lower in the mice treated with lactobacilli than in the non-lactobacilli treated mice. Eventhough the survival of the lactobacilli was highly affected by the norfloxacin treatment, the uropathogenic E. coli colonization always decreased more than the lactobacilli population did and often completely disappeared in those animals which were treated with both norfloxacin and probiotic lactobacilli. Through this experimental model one can conclude that lactobacilli increases the effectiveness of the norfloxacin medication in the prevention and treatment of UTI produced by E. coli. Further studies are being performed to determine the mechanisms involved in this probiotic effect.Fil: Silva, Clara del Valle. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; ArgentinaFil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaMedwell online2006-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/58961Silva, Clara del Valle; Nader, Maria Elena Fatima; Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli; Medwell online; International Journal of Molecular Medicine and Advances Sciences; 2; 4; 12-2006; 360-3651813-176x1994-4624CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.medwelljournals.com/archive.php?jid=1813-176xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:45:13Zoai:ri.conicet.gov.ar:11336/58961instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:45:14.264CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
title |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
spellingShingle |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli Silva, Clara del Valle Probiotics Norfloxacin Urinary Tract Infections Prevention E. Coli L. Fermentum Recurrence |
title_short |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
title_full |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
title_fullStr |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
title_full_unstemmed |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
title_sort |
Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli |
dc.creator.none.fl_str_mv |
Silva, Clara del Valle Nader, Maria Elena Fatima |
author |
Silva, Clara del Valle |
author_facet |
Silva, Clara del Valle Nader, Maria Elena Fatima |
author_role |
author |
author2 |
Nader, Maria Elena Fatima |
author2_role |
author |
dc.subject.none.fl_str_mv |
Probiotics Norfloxacin Urinary Tract Infections Prevention E. Coli L. Fermentum Recurrence |
topic |
Probiotics Norfloxacin Urinary Tract Infections Prevention E. Coli L. Fermentum Recurrence |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
This study was perfomed to evaluate the effect of the treatment of norfloxacin, as an antimicrobial agent, on the uropathogenic Escherichia coli colonization in mice, complemented by Lactobacilli as probiotics. Norfloxacin (5.5 mg. Kg-1 dose) was administred orally before and after the challenge with E. coli. The animals were also inoculated intra-urethrally with agarose beads containing L. fermentum. The population of the microorganisms in the urogenital tract was measured various days throughout the study. Using either 1 or 3 doses of norfloxacion befor or after the animal had been challenged with E. coli bacteria, reduced the E. coli population the urinary tract. The Norfloxacin treatment after the animals were administered 1 or 3 doses of agarose beads of lactobacilli significantly affected the viability of the lactic acid bacteria in all of the urinary tract organs and the number of E. coly (regardless to when the antibiotic was inoculated) was lower in the mice treated with lactobacilli than in the non-lactobacilli treated mice. Eventhough the survival of the lactobacilli was highly affected by the norfloxacin treatment, the uropathogenic E. coli colonization always decreased more than the lactobacilli population did and often completely disappeared in those animals which were treated with both norfloxacin and probiotic lactobacilli. Through this experimental model one can conclude that lactobacilli increases the effectiveness of the norfloxacin medication in the prevention and treatment of UTI produced by E. coli. Further studies are being performed to determine the mechanisms involved in this probiotic effect. Fil: Silva, Clara del Valle. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia; Argentina Fil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina |
description |
This study was perfomed to evaluate the effect of the treatment of norfloxacin, as an antimicrobial agent, on the uropathogenic Escherichia coli colonization in mice, complemented by Lactobacilli as probiotics. Norfloxacin (5.5 mg. Kg-1 dose) was administred orally before and after the challenge with E. coli. The animals were also inoculated intra-urethrally with agarose beads containing L. fermentum. The population of the microorganisms in the urogenital tract was measured various days throughout the study. Using either 1 or 3 doses of norfloxacion befor or after the animal had been challenged with E. coli bacteria, reduced the E. coli population the urinary tract. The Norfloxacin treatment after the animals were administered 1 or 3 doses of agarose beads of lactobacilli significantly affected the viability of the lactic acid bacteria in all of the urinary tract organs and the number of E. coly (regardless to when the antibiotic was inoculated) was lower in the mice treated with lactobacilli than in the non-lactobacilli treated mice. Eventhough the survival of the lactobacilli was highly affected by the norfloxacin treatment, the uropathogenic E. coli colonization always decreased more than the lactobacilli population did and often completely disappeared in those animals which were treated with both norfloxacin and probiotic lactobacilli. Through this experimental model one can conclude that lactobacilli increases the effectiveness of the norfloxacin medication in the prevention and treatment of UTI produced by E. coli. Further studies are being performed to determine the mechanisms involved in this probiotic effect. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/58961 Silva, Clara del Valle; Nader, Maria Elena Fatima; Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli; Medwell online; International Journal of Molecular Medicine and Advances Sciences; 2; 4; 12-2006; 360-365 1813-176x 1994-4624 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/58961 |
identifier_str_mv |
Silva, Clara del Valle; Nader, Maria Elena Fatima; Norfloxacin treatment on E. coli in the urinary tract of mice: Effect of probiotic Lactobacilli; Medwell online; International Journal of Molecular Medicine and Advances Sciences; 2; 4; 12-2006; 360-365 1813-176x 1994-4624 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.medwelljournals.com/archive.php?jid=1813-176x |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Medwell online |
publisher.none.fl_str_mv |
Medwell online |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613421270564864 |
score |
13.070432 |